A growing body of evidence has shown that chronic treatment with fluoxetine, a widely prescribed medication for treatment of depression, can affect synaptic plasticity in the adult central nervous system. However, it is not well understood whether acute fluoxetine influences synaptic plasticity, especially on hippocampal CA1 long-term depression (LTD), and if so, whether it subsequently impacts hippocampal-dependent spatial memory. Here, we reported that LTD facilitated by elevatedplatform stress in hippocampal slices was completely prevented by fluoxetine administration (10 mg/kg, i.p.) 30 min before stress. The LTD was not, however, significantly inhibited by fluoxetine administration immediately after stress. Similarly, fluoxetine incubation (10 μM) during electrophysiological recordings also displayed no influence on the stress-facilitated LTD. In addition, behavioral results showed that a single fluoxetine treatment 30 min before but not after acute stress fully reversed the impairment of spatial memory retrieval in the Morris water maze paradigm. Taken together, these results suggest that acute fluoxetine treatment only before, but not after stress, can prevent hippocampal CA1 LTD and spatial memory retrieval impairment caused by behavioral stress in adult animals.
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), is widely used to treat major depressive disorder. The antidepressant effect of fluoxetine is mediated by a series of cellular and molecular events, including changes in synaptic plasticity. For example, chronic fluoxetine treatment reinstates ocular dominance plasticity in the primary visual cortex of adult rats, a form of developmentally regulated plasticity that is significantly reduced in the mature brain 1 , and enhances long-term potentiation (LTP) in the dentate gyrus of adult mice 2 . Nonetheless, some studies reported contradictory results that chronic fluoxetine treatment suppresses LTP in the primary auditory cortex 3 and hippocampus [4] [5] [6] of adult rats. However, all these studies have focused on the potential role of chronic fluoxetine treatment in LTP, whether enhancement or impairment. Correlations between fluoxetine and LTD modulation have not Scientific RepoRts | 5:12667 | DOi: 10.1038/srep12667 been extensively investigated. One possibility is that LTD is difficult to be induced by classical low frequency stimulation (LFS) protocols in adult animals [7] [8] [9] . It has been well documented that exposure to acute stress impairs hippocampal LTP 6, 10, 11 and facilitates LTD 12, 13 in rats, as well as to produce learning and memory impairment in rats and monkeys 8, 14, 15 . Previous study has shown that a single systemic injection of fluoxetine is able to reverse the impairment in LTP at synapses from the hippocampus to prefrontal cortex in the rats, caused by stress on an elevated platform 16, 17 . However, it is not clear whether acute fluoxetine can inhibit acute stress-facilitated LTD in the hippocampus, and if so, it may rescue stress-induced spatial memory retrieval impairment.
In the present study, we investigated the effects of acute fluoxetine treatment on stress-induced hippocampal CA1 LTD and spatial memory retrieval impairment using a combination of in vitro electrophysiological and behavioral assessments in adult rats.
Results
Single fluoxetine treatment before acute stress inhibits stress-facilitated hippocampal CA1 LTD. Previous studies have shown that hippocampal LTD is difficult to induced in adult rats, while acute stress activates the hypothalamus-pituitary-adrenal (HPA) axis, resulting in elevated secretion of corticosterone 15 , and subsequently facilitates LTD production 8, 12 . Consistent with these results, we found that acute elevated-platform stress dramatically increased plasma corticosterone level compared with control (unstress: n = 6, 94.9 ± 14.6 ng/ml; stress: n = 6, 304.1 ± 31.1 ng/ml, p = 0.001 vs. unstress), and a typical LFS protocol (1 Hz for 15 min) failed to induce hippocampal CA1 LTD in saline control (saline: n = 6, 97.3 ± 3.5%, p = 0.248 vs. baseline; Fig. 1A ,E), whereas elevated-platform stress enable LFS to induce a reliable LTD (saline + stress: n = 7, 79.1 ± 2.5%, p < 0.001 vs. baseline, p = 0.004 vs. saline; Fig. 1B,E) . Recent studies have reported that fluoxetine can reverse the impairment of LTP caused by stress 16, 17 . Thus, it is reasonable to assume that fluoxetine may also inhibit hippocampal LTD facilitated by acute stress. As expected, fluoxetine administration (10 mg/kg, i.p.) 30 min before elevated-platform stress succeeded in preventing hippocampal CA1 LTD in stressed rats (fluoxetine + stress: n = 6, 97.3 ± 4.5%, p = 0.454 vs. baseline, p = 0.999 vs. saline, p = 0.010 vs. saline + stress; Fig. 1D ,E), while fluoxetine per se had no effect on LTD induction (fluoxetine: n = 5, 96.3 ± 2.6%, p = 0.138 vs. baseline; Fig. 1C,E) . These results suggest that pretreatment of fluoxetine can inhibit hippocampal CA1 LTD facilitated by acute behavioral stress.
Single fluoxetine treatment immediately after acute stress has no effect on stress-facilitated hippocampal CA1 LTD. Next, we wanted to determine whether fluoxetine administration immediately after stress had the same blocking effects on stress-facilitated hippocampal LTD. The results showed that no LTD was induced by LFS in control group (saline: n = 5, 97.9 ± 4.3%, p = 0.347 vs. baseline; Fig. 2A,E) , and elevated-platform stress enable LFS to induce a reliable LTD (stress + saline: n = 5, 75.3 ± 2.6%, p = 0.002 vs. baseline, p = 0.002 vs. saline; Fig. 2B,E) . Surprisingly, fluoxetine administration immediately after stress failed to prevent hippocampal CA1 LTD in stressed rats (stress + fluoxetine: n = 10, 77.9 ± 2.8%, p < 0.001 vs. baseline, p = 0.002 vs. saline, p = 0.910 vs. stress + saline; Fig. 2D ,E), while fluoxetine per se had no effect on LTD induction (fluoxetine: n = 5, 98.5 ± 4.0%, p = 0.799 vs. baseline; Fig. 2C,E) . These results suggest that a single treatment with fluoxetine after stress has no effect on hippocampal CA1 LTD facilitated by acute behavioral stress.
Bath application of fluoxetine has no effect on acute stress-facilitated hippocampal CA1 LTD. To further confirm the influence of fluoxetine on stress-facilitated hippocampal LTD, we next examined the induction of hippocampal CA1 LTD via direct bath application of fluoxetine during recording. The results showed that no LTD was observed after LFS delivery in ACSF control (ACSF: n = 6, 96.1 ± 3.6%, p = 0.220 vs. baseline; Fig. 3A,E) , and elevated-platform stress enable LFS to induce a reliable LTD (stress + ACSF: n = 6, 73.7 ± 3.7%, p < 0.001 vs. baseline, p = 0.002 vs. ACSF; Fig. 3B,E) . Similar to fluoxetine administration immediately after behavioral stress, bath application of fluoxetine also failed to prevent hippocampal CA1 LTD in stressed rats (stress + fluoxetine: n = 6, 79.9 ± 2.6%, p = 0.002 vs. baseline, p = 0.018 vs. ACSF, p = 0.996 vs. stress + ACSF; Fig. 3D ,E), while fluoxetine per se had no effect on LTD induction (fluoxetine: n = 5, 95.0 ± 3.2%, p = 0.203 vs. baseline; Fig. 3C ,E). These results suggest that direct bath application of fluoxetine during recording has no effect on hippocampal CA1 LTD facilitated by acute behavioral stress.
Single fluoxetine treatment before acute stress prevents the impairment of spatial memory retrieval caused by stress. Since previous report has shown that hippocampal LTD is necessary and sufficient to mediate acute stress-induced impairment of spatial memory retrieval 8 , it is reasonable to hypothesize that fluoxetine treatment before but not after acute stress may prevent spatial memory retrieval impairment caused by stress. To test this hypothesis, we introduced a widely-used hippocampal-dependent behavioral task, the Morris water maze. In the present experiments, rats were trained to remember the location of a hidden platform over 6 days (Fig. 4A ). Twenty-four hours later, their memory for the platform location was tested by using a retrieval trial with the platform absent from the pool. During the retrieval test, stressed rats spent much less time in the target quadrant where the hidden platform was located (stress: n = 10, 17.0 ± 1.6 s, p = 0.005 vs. control; Fig. 4B ), compared to control, p = 0.026 vs. fluoxetine + stress, p = 0.430 vs. stress; Fig. 4C ) and latency to cross the location of hidden platform (control: 11.3 ± 4.0 s; stress: 39.5 ± 5.6 s, p = 0.001 vs. control; fluoxetine + stress: 9.5 ± 1.7 s, p = 0.992 vs. control, p < 0.001 vs. stress; stress + fluoxetine: 25.8 ± 6.1 s, p = 0.048 vs. control, p = 0.046 vs. fluoxetine + stress, p = 0.164 vs. stress; Fig. 4D ) further confirmed that stress impaired spatial memory retrieval, and fluoxetine treatment before, but not after stress could prevent this impairment. Taken together, these results suggest that a single systemic injection of fluoxetine before but not after behavioral stress can prevent the stress-induced impairment of spatial memory retrieval. 
Discussion
The main findings of the present study are an acute injection of fluoxetine before elevated-platform stress prevented stress-facilitated LTD in the CA1 area of hippocampus. In contrast, fluoxetine injection immediately after stress displayed no influence on the LTD. More importantly, by correspondingly applying fluoxetine before behavioral stress, the impairment of spatial memory retrieval caused by stress can be fully reversed. We have therefore provided evidence that acute fluoxetine may block stress-facilitated hippocampal LTD and subsequently rescue memory retrieval impairment. It has been well documented that hippocampal LTD is difficult to be induced by classical LFS protocol in adult rats [7] [8] [9] . However, as demonstrated previously 8, 12 and convincingly replicated here (Figs 1-3 ), behavioral stress enable LFS to induce a reliable hippocampal LTD. One possible explanation is that stress-enabled LTD may result from hippocampal glucocorticoid receptor activation 7, 18 , which leads to an increase in glutamate concentration 19, 20 and decrease in γ -amino-butyric acid (GABA) concentration 21 in several brain areas including hippocampus. The alteration of glutamate and GABA level in the hippocampus may result in a lower threshold for LTD induction after stress. However, acute fluoxetine administration significantly elevates GABA level 22 , and then the threshold for LTD induction may return to physiological level. In the current experiment, thus, no obvious LTD was observed in the hippocampus of stressed rats that were pretreated with fluoxetine (Fig. 1) . However, Rubio and colleagues have recently reported that a single dose of fluoxetine (0.7 mg/kg, i.p.) administrated 24 h before LFS delivery had no effect on LTD induction at CA3-CA1 synapses 4 . Two important factors in explaining these contradictory findings may be the concentrations and administration time of fluoxetine used to prevent LTD induction. Notably, fluoxetine treatment after behavioral stress had no significant influence on hippocampal LTD production in the present study (Figs 2-3) , which suggested that fluoxetine may exert its actions before but not after the increase in corticosterone secretion. Thus, further experiments need to be performed to determine the exact mechanism underlying different effects of fluoxetine application before or after stress on the restoration of synaptic plasticity in the hippocampus. Alternatively, recent studies show that the chronic effects of antidepressant agents including fluoxetine, are involved in the regulation of intracellular transduction pathways, implicating changes in the cyclic adenosine monophosphate (cAMP) second messenger system, cAMP response element binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in antidepressant action 23 . Given that all these factors have been suggested to contribute to synaptic plasticity 24, 25 , future studies examining the activities of these transduction pathways and neurotrophic factors after acute fluoxetine treatment will help determine whether the prevention effect of fluoxetine on stress-facilitated LTD can be attributed to its modulation role in these factors.
Hippocampal LTD has been proposed to play a critical role in spatial learning and memory, especially in memory retrieval 8 . Indeed, we here confirmed that stress facilitated hippocampal LTD and subsequently induced a dramatic impairment of spatial memory retrieval (Fig. 4) . By blocking hippocampal LTD caused by stress with pretreatment of fluoxetine, the impairment of spatial memory retrieval was fully reversed (Fig. 4) . It is noteworthy that pretreatment of fluoxetine not only blocked stress-enabled LTD (Fig. 1) but also prevented the stress-induced impairment of LTP 16, 17 . Given the previous conjecture that the balance between LTP and LTD may be necessary for learning and memory, it cannot occlude the possibility that normalization of hippocampal LTP after pretreatment of fluoxetine also plays a critical role in preventing the impairment of spatial memory retrieval caused by stress.
In summary, the present work shows that an acute injection of fluoxetine before, but not after elevated-platform stress, reverses the disruption of spatial memory retrieval caused by stress. Furthermore, these behavioral changes are accompanied by the prevention of stress-facilitated LTD in the hippocampus. Thus, these results suggest that acute fluoxetine may serve as a potential therapeutic agent against stress-related psychiatric disorders besides chronic use in major depressive disorder.
Methods

Animals. Adult male Sprague-Dawley rats (200-250 g) were obtained from Chongqing Medical University
Animal House Center) and were maintained at Children's Hospital of Chongqing Medical University Animal Care Centre in accordance with the guidelines set forth by Chongqing Medical University Animal Care and Use Committee. Animals were pair-housed in plastic cages in a temperature-controlled (21 °C) colony room on a 12/12 h light/dark cycle. Food and water were available ad libitum. All experiment protocols were approved by Chongqing Medical University Animal Care and Use Committee. All efforts were made to minimize the number of animals used.
Drugs and treatment.
Fluoxetine was purchased from Sigma-Aldrich. For in vivo treatment, it was dissolved in 0.9% sterile saline at 10 mg/ml, while it was dissolved in artificial cerebrospinal fluid (ACSF) at 10 μ M for in vitro treatment.
Elevated-platform stress. Behavioral stress protocol was similarly to that described previously 8, 13 by placing rats on an elevated Plexiglas platform (1.5 m tall, 21 × 21 cm) in a brightly lit room for 30 min 13 . Some rats were subjected to a single fluoxetine (10 mg/kg, i.p.) or the same volume of sterile saline treatment 30 min before stress, and the other rats were treated with fluoxetine or saline immediately after stress. Electrophysiological recordings or behavioral tests were performed 1 h after stress.
Plasma levels of corticosterone. During the rats were decapitated for slice preparation, blood samples were taken and centrifuged and the serum was stored at − 20 °C. Plasma corticosterone levels were determined by using a commercial corticosterone ELISA kit according to the instructions of the manufacturer (Enzo Life Sciences).
Slice Preparation and Electrophysiology. Slices were prepared by using techniques similar to those described previously 26, 27 . In brief, rats were deeply anesthetized using urethane (1.5 g/kg, i.p.) and transcardially perfused with NMDG ACSF prior to decapitation. NMDG ACSF contained (in mM): NMDG 93, HCl 93, KCl 2.5, NaH2PO4 1.2, CaCl2 0.5, MgSO4 10, NaHCO3 30, HEPES 20, Na-ascorbate 5.0, Na-pyruvate 3.0, Thiourea 2.0, NAC 12, and D-glucose 25, pH 7.3. Rat brains were rapidly dissected from the skull and placed for sectioning in ice-cold cutting solution (NMDG ACSF) bubbled with 95% O2 and 5% CO2. Coronal hippocampal slices (400 μ m thickness) were sectioned from the middle third of hippocampus with a vibratome (VT1000S, Leica Microsystems, Bannockburn, IL) in cutting solution. Slices were then incubated in oxygenated HEPES ACSF for 1 h at 30 °C. HEPES ACSF contained (in mM): NaCl 92, KCl 2.5, NaH2PO4 1.2, CaCl2 0.5, MgSO4 10, NaHCO3 30, HEPES 20, Na-ascorbate 5.0, Na-pyruvate 3.0, Thiourea 2.0, NAC 12, and 25 D-glucose, pH 7.3.
Extracellular recordings were made in the CA1 region of the hippocampus at room temperature (about 25 °C) using a Multiclamp EPC 10 amplifier (HEKA Electronics, Lambrecht/Pfalz, Germany). A bipolar platinum-iridium stimulating electrode was placed among the Schaffer collateral/commissural pathways to elicit field excitatory postsynaptic potentials (fEPSPs), which were recorded from the CA1 stratum radiatum using a glass microelectrode (1 ~ 3 MΩ ) filled with 3 M NaCl. The recording Scientific RepoRts | 5:12667 | DOi: 10.1038/srep12667 electrodes were pulled from borosilicate glass tubing (1.5 mm outer diameter, 0.84 mm inner diameter; World Precision Instruments, Inc.) with a Brown-Flaming micropipette puller (P-97; Sutter Instruments Co.). fEPSPs were evoked by square-wave stimulations (pulse width, 0.1 ms). Test fEPSPs were evoked at a frequency of 0.033 Hz and at a stimulus intensity adjusted to about 50% of the maximal response size. After a 20-min stable baseline, LTD was induced by LFS (900 pulses at 1 Hz).
Morris water maze test. Spatial learning and memory were examined with the Morris water maze using procedures similar to those described previously 28, 29 . In brief, the Morris water maze consisted of a circular fiberglass pool (180-cm diameter) filled with water (25 ± 1 °C) that was made opaque with black non-toxic paint. The pool was surrounded by light blue curtains, and three distal visual cues were fixed to the curtains. Four floor light sources of equal power provided uniform illumination to the pool and testing room. A CCD camera suspended above the pool center recorded the swim paths of the animals, and the video output was digitized with an Any-maze tracking system (Stoelting, USA). The pool was artificially divided into four quadrants, i.e., N, E, S, and W. The Morris water maze test included spatial training and a probe test. Twenty-four hours before the spatial training, 40 rats were allowed to adapt to the maze via 60 s of free swimming. The animals were then trained in the spatial learning task for 4 trials per day for 6 consecutive days. In each trial, rats were placed in the water at one of four starting positions (N, E, S, or W) facing to the pool wall. The rats were then required to swim to find the hidden platform (13 cm in diameter, located in the SW quadrant), which was submerged 1 cm under the water. During each trial, the rats were allowed to swim until they found the hidden platform where they remained for 20 s before being returned to a holding cage. The rats that failed to find the hidden platform within 60 s were guided to the platform where they remained for 20 s.
Twenty-four hours after the final training trial, a retrieval test was performed which consisted of a 60-s free swimming period at a novel drop point with the hidden platform absent, and the swimming paths were recorded. During retrieval test, rats were divided into 2 groups: non-stressed control (n = 8) and stressed group (n = 32). To determine the effect of fluoxetine on stress-induced spatial memory retrieval impairment, rats in stressed group were subdivided into 3 subgroups. Twelve rats were subjected to an acute injection of fluoxetine (10 mg/kg, i.p.) 30 min before elevated-platform stress (fluoxetine + stress), and 10 rats were injected with fluoxetine immediately after stress (stress + fluoxetine). The remaining stressed rats were injected with saline vehicle (stress).
Statistical analysis. All data were expressed as the average percent change from baseline ± SEM and were analyzed by one-way ANOVA followed by post hoc Turkey's tests where appropriate, with treatment as the between-subjects factor. Significance level was set at p < 0.05.
